ESC 365 - Atrial fibrillation and outcome in HCM: the American vs. European approach to risk stratification

EHRA Premium Access

Atrial fibrillation and outcome in HCM: the American vs. European approach to risk stratification

Session: Hypertrophic cardiomyopathy genetics and clinical management

Topic: Molecular biology / genetics

Speaker: Professor E. Arbustini (Pavia, IT)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Professor Eloisa Arbustini

Foundation IRCCS Policlinic San Matteo - University of Pavia, Pavia (Italy)

7 presentations

5 followers

3 more presentations in this session

Diagnostic and prognostic role of genotyping in HCM.

Speaker: Professor P. Charron (Paris, FR)

Risk stratification of HCM in 2017: the European approach.

Speaker: Professor P. Elliott (London, GB)

Ablation in HCM.

Speaker: Professor L. Di Biase (The Bronx, US)

Access the full session

Hypertrophic cardiomyopathy genetics and clinical management

Speakers: Professor E. Arbustini, Professor P. Charron, Professor P. Elliott, Professor L. Di Biase

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources